Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with…
Idorsias daridorexant in women during menopausal transition age with insomnia
New analysis of a Phase 3 study of daridorexant shows that 50…
